MedPath

Patient Interviews to investigate psychosocial disease burden in patients with Psoriasis vulgaris in Japa

Not Applicable
Conditions
Psoriasis vulgaris
Registration Number
JPRN-UMIN000051977
Lead Sponsor
AbbVie GK.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Unable to attend or understand and respond to the questions posed during an audio-recorded interview conducted using one of the following formats: online video, in-person, or phone call (online or landline).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In this qualitative study, the primary endpoints broadly include the description of the concepts of highest relevance experienced by PsO patients related to the psychosocial burden of disease and how it has impacted their daily lives, social relationships, and life course decisions.
Secondary Outcome Measures
NameTimeMethod
ot applicable
© Copyright 2025. All Rights Reserved by MedPath